{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T22:33:34Z","timestamp":1780439614231,"version":"3.54.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T00:00:00Z","timestamp":1679356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T00:00:00Z","timestamp":1679356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s12010-023-04385-1","type":"journal-article","created":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T09:04:23Z","timestamp":1679389463000},"page":"6840-6855","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Anti-Liver Fibrosis Role of miRNA-96-5p via Targeting FN1 and Inhibiting ECM-Receptor Interaction Pathway"],"prefix":"10.1007","volume":"195","author":[{"given":"Yong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tengfei","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanrong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingzhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2706-6232","authenticated-orcid":false,"given":"Xinguo","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,21]]},"reference":[{"key":"4385_CR1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.mam.2018.09.002","volume":"65","author":"M Parola","year":"2019","unstructured":"Parola, M., & Pinzani, M. (2019). Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues. Molecular Aspects Of Medicine, 65, 37\u201355.","journal-title":"Molecular Aspects Of Medicine"},{"issue":"3","key":"4385_CR2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","volume":"18","author":"T Kisseleva","year":"2021","unstructured":"Kisseleva, T., & Brenner, D. (2021). Molecular and cellular mechanisms of liver fibrosis and its regression. Nature Reviews. Gastroenterology & Hepatology, 18(3), 151\u2013166.","journal-title":"Nature Reviews. Gastroenterology & Hepatology"},{"key":"4385_CR3","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.matbio.2018.04.006","volume":"68-69","author":"D Schuppan","year":"2018","unstructured":"Schuppan, D., Ashfaq-Khan, M., Yang, A. T., & Kim, Y. O. (2018). Liver fibrosis: Direct antifibrotic agents and targeted therapies. Matrix Biology, 68-69, 435\u2013451.","journal-title":"Matrix Biology"},{"key":"4385_CR4","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.matbio.2017.12.012","volume":"68-69","author":"E Roeb","year":"2018","unstructured":"Roeb, E. (2018). Matrix metalloproteinases and liver fibrosis (translational aspects). Matrix Biology, 68-69, 463\u2013473.","journal-title":"Matrix Biology"},{"key":"4385_CR5","doi-asserted-by":"crossref","unstructured":"Geervliet, E., & Bansal, R. (2020). Matrix metalloproteinases as potential biomarkers and therapeutic targets in liver diseases. Cells, 9(5), 1212","DOI":"10.3390\/cells9051212"},{"key":"4385_CR6","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.matbio.2017.11.011","volume":"68-69","author":"M Roderfeld","year":"2018","unstructured":"Roderfeld, M. (2018). Matrix metalloproteinase functions in hepatic injury and fibrosis. Matrix Biology, 68-69, 452\u2013462.","journal-title":"Matrix Biology"},{"key":"4385_CR7","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.ijbiomac.2020.02.087","volume":"150","author":"J Wang","year":"2020","unstructured":"Wang, J., Zhang, Q., Li, S., Chen, Z., Tan, J., Yao, J., et al. (2020). Low molecular weight fucoidan alleviates diabetic nephropathy by binding fibronectin and inhibiting ECM-receptor interaction in human renal mesangial cells. International Journal Of Biological Macromolecules, 150, 304\u2013314.","journal-title":"International Journal Of Biological Macromolecules"},{"issue":"9","key":"4385_CR8","doi-asserted-by":"publisher","first-page":"6140","DOI":"10.1111\/jcmm.14490","volume":"23","author":"Y Li","year":"2019","unstructured":"Li, Y., Feng, C., Gao, M., Jin, M., Liu, T., Yuan, Y., et al. (2019). MicroRNA-92b-5p modulates melatonin-mediated osteogenic differentiation of bone marrow mesenchymal stem cells by targeting ICAM-1. Journal Of Cellular And Molecular Medicine, 23(9), 6140\u20136153.","journal-title":"Journal Of Cellular And Molecular Medicine"},{"issue":"4","key":"4385_CR9","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1136\/gutjnl-2020-322526","volume":"70","author":"X Wang","year":"2021","unstructured":"Wang, X., He, Y., Mackowiak, B., & Gao, B. (2021). MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases. Gut, 70(4), 784\u2013795.","journal-title":"Gut"},{"key":"4385_CR10","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13578-017-0161-7","volume":"7","author":"XP Jiang","year":"2017","unstructured":"Jiang, X. P., Ai, W. B., Wan, L. Y., Zhang, Y. Q., & Wu, J. F. (2017). The roles of microRNA families in hepatic fibrosis. Cell Bioscience, 7, 34.","journal-title":"Cell Bioscience"},{"key":"4385_CR11","doi-asserted-by":"publisher","first-page":"696069","DOI":"10.3389\/fimmu.2021.696069","volume":"12","author":"L Liu","year":"2021","unstructured":"Liu, L., Wang, P., Wang, Y. S., Zhang, Y. N., Li, C., Yang, Z. Y., et al. (2021). MiR-130a-3p alleviates liver fibrosis by suppressing HSCs activation and skewing macrophage to Ly6C(lo) phenotype. Frontiers Immunology, 12, 696069.","journal-title":"Frontiers Immunology"},{"issue":"5","key":"4385_CR12","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1002\/hep.29690","volume":"67","author":"AK Singh","year":"2018","unstructured":"Singh, A. K., Rooge, S. B., Varshney, A., Vasudevan, M., Bhardwaj, A., Venugopal, S. K., et al. (2018). Global microRNA expression profiling in the liver biopsies of hepatitis B virus-infected patients suggests specific microRNA signatures for viral persistence and hepatocellular injury. Hepatology, 67(5), 1695\u20131709.","journal-title":"Hepatology"},{"issue":"1","key":"4385_CR13","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00109-017-1593-6","volume":"96","author":"K Yu","year":"2018","unstructured":"Yu, K., Li, N., Cheng, Q., Zheng, J., Zhu, M., Bao, S., et al. (2018). miR-96-5p prevents hepatic stellate cell activation by inhibiting autophagy via ATG7. Journal Of Molecular Medicine (Berlin), 96(1), 65\u201374.","journal-title":"Journal Of Molecular Medicine (Berlin)"},{"issue":"7","key":"4385_CR14","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.7150\/ijbs.41293","volume":"16","author":"Y Zheng","year":"2020","unstructured":"Zheng, Y., Cui, B., Sun, W., Wang, S., Huang, X., Gao, H., et al. (2020). Potential crosstalk between liver and extra-liver organs in mouse models of acute liver injury. International Journal Of Biological Sciences, 16(7), 1166\u20131179.","journal-title":"International Journal Of Biological Sciences"},{"issue":"2","key":"4385_CR15","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/hep.29834","volume":"68","author":"JL Duan","year":"2018","unstructured":"Duan, J. L., Ruan, B., Yan, X. C., Liang, L., Song, P., Yang, Z. Y., et al. (2018). Endothelial Notch activation reshapes the angiocrine of sinusoidal endothelia to aggravate liver fibrosis and blunt regeneration in mice. Hepatology, 68(2), 677\u2013690.","journal-title":"Hepatology"},{"key":"4385_CR16","doi-asserted-by":"crossref","unstructured":"Caligiuri, A., Gentilini, A., Pastore, M., Gitto, S., & Marra, F. (2021). Cellular and molecular mechanisms underlying liver fibrosis regression. Cells, 10(10).","DOI":"10.3390\/cells10102759"},{"issue":"4","key":"4385_CR17","first-page":"100316","volume":"3","author":"Y Iwakiri","year":"2021","unstructured":"Iwakiri, Y., & Trebicka, J. (2021). Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapy. Journal of High Energy Physics Reports, 3(4), 100316.","journal-title":"Journal of High Energy Physics Reports"},{"key":"4385_CR18","doi-asserted-by":"publisher","first-page":"105739","DOI":"10.1016\/j.phrs.2021.105739","volume":"170","author":"N Bourebaba","year":"2021","unstructured":"Bourebaba, N., & Marycz, K. (2021). Hepatic stellate cells role in the course of metabolic disorders development - a molecular overview. Pharmacology Research, 170, 105739.","journal-title":"Pharmacology Research"},{"issue":"6","key":"4385_CR19","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.matbio.2005.06.008","volume":"24","author":"Y Mao","year":"2005","unstructured":"Mao, Y., & Schwarzbauer, J. E. (2005). Fibronectin fibrillogenesis, a cell-mediated matrix assembly process. Matrix Biology, 24(6), 389\u2013399.","journal-title":"Matrix Biology"},{"issue":"7","key":"4385_CR20","doi-asserted-by":"publisher","first-page":"a005041","DOI":"10.1101\/cshperspect.a005041","volume":"3","author":"JE Schwarzbauer","year":"2011","unstructured":"Schwarzbauer, J. E., & DeSimone, D. W. (2011). Fibronectins, their fibrillogenesis, and in vivo functions. Cold Spring Harbor Perspectives In Biology, 3(7).","journal-title":"Cold Spring Harbor Perspectives In Biology"},{"issue":"1","key":"4385_CR21","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.immuni.2017.12.007","volume":"48","author":"A Glasner","year":"2018","unstructured":"Glasner, A., Levi, A., Enk, J., Isaacson, B., Viukov, S., Orlanski, S., et al. (2018). NKp46 receptor-mediated interferon-gamma production by natural killer cells increases fibronectin 1 to alter tumor architecture and control metastasis. Immunity, 48(1), 107\u2013119 e104.","journal-title":"Immunity"},{"issue":"8","key":"4385_CR22","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1080\/15548627.2019.1687985","volume":"16","author":"Z Zhang","year":"2020","unstructured":"Zhang, Z., Guo, M., Li, Y., Shen, M., Kong, D., Shao, J., et al. (2020). RNA-binding protein ZFP36\/TTP protects against ferroptosis by regulating autophagy signaling pathway in hepatic stellate cells. Autophagy, 16(8), 1482\u20131505.","journal-title":"Autophagy"},{"issue":"9","key":"4385_CR23","doi-asserted-by":"publisher","first-page":"699","DOI":"10.2217\/epi-2020-0449","volume":"13","author":"H Su","year":"2021","unstructured":"Su, H., Xie, J., Wen, L., Wang, S., Chen, S., Li, J., et al. (2021). LncRNA Gas5 regulates Fn1 deposition via Creb5 in renal fibrosis. Epigenomics, 13(9), 699\u2013713.","journal-title":"Epigenomics"},{"issue":"1","key":"4385_CR24","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1080\/10717544.2021.2008054","volume":"28","author":"YW Zhang","year":"2021","unstructured":"Zhang, Y. W., Tu, L. L., Zhang, Y., Pan, J. C., Zheng, G. L., & Yin, L. N. (2021). Liver-targeted delivery of asiatic acid nanostructured lipid carrier for the treatment of liver fibrosis. Drug Delivery, 28(1), 2534\u20132547.","journal-title":"Drug Delivery"},{"key":"4385_CR25","doi-asserted-by":"publisher","first-page":"640667","DOI":"10.3389\/fcell.2021.640667","volume":"9","author":"X Li","year":"2021","unstructured":"Li, X., Chen, R., Kemper, S., & Brigstock, D. R. (2021). Structural and functional characterization of fibronectin in extracellular vesicles from hepatocytes. Frontiers in Cell and Developmental Biology, 9, 640667.","journal-title":"Frontiers in Cell and Developmental Biology"},{"key":"4385_CR26","doi-asserted-by":"crossref","unstructured":"Kwon, E. Y., Shin, S. K., & Choi, M. S. (2018). Ursolic acid attenuates hepatic steatosis, fibrosis, and insulin resistance by modulating the circadian rhythm pathway in diet-induced obese mice. Nutrients, 10(11).","DOI":"10.3390\/nu10111719"},{"key":"4385_CR27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.trsl.2019.07.007","volume":"214","author":"Z Zhao","year":"2019","unstructured":"Zhao, Z., Lin, C. Y., & Cheng, K. (2019). siRNA- and miRNA-based therapeutics for liver fibrosis. Translational Research, 214, 17\u201329.","journal-title":"Translational Research"},{"key":"4385_CR28","doi-asserted-by":"publisher","first-page":"112132","DOI":"10.1016\/j.biopha.2021.112132","volume":"143","author":"S Ghafouri-Fard","year":"2021","unstructured":"Ghafouri-Fard, S., Abak, A., Talebi, S. F., Shoorei, H., Branicki, W., Taheri, M., et al. (2021). Role of miRNA and lncRNAs in organ fibrosis and aging. Biomedicine & Pharmacotherapy, 143, 112132.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"10","key":"4385_CR29","doi-asserted-by":"publisher","first-page":"e2025242118","DOI":"10.1073\/pnas.2025242118","volume":"118","author":"P Piccolo","year":"2021","unstructured":"Piccolo, P., Ferriero, R., Barbato, A., Attanasio, S., Monti, M., Perna, C., et al. (2021). Up-regulation of miR-34b\/c by JNK and FOXO3 protects from liver fibrosis. Proceedings of the National Academy of Sciences of the United States of America, 118(10).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"4385_CR30","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41392-020-0169-z","volume":"5","author":"X Yang","year":"2020","unstructured":"Yang, X., Ma, L., Wei, R., Ye, T., Zhou, J., Wen, M., et al. (2020). Twist1-induced miR-199a-3p promotes liver fibrosis by suppressing caveolin-2 and activating TGF-beta pathway. Signal Transduction and Targeted Therapy, 5(1), 75.","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"9","key":"4385_CR31","doi-asserted-by":"publisher","first-page":"12780","DOI":"10.18632\/aging.202947","volume":"13","author":"L Yi","year":"2021","unstructured":"Yi, L., Ai, K., Li, H., Qiu, S., Li, Y., Wang, Y., et al. (2021). CircRNA_30032 promotes renal fibrosis in UUO model mice via miRNA-96-5p\/HBEGF\/KRAS axis. Aging (Albany NY), 13(9), 12780\u201312799.","journal-title":"Aging (Albany NY)"},{"key":"4385_CR32","doi-asserted-by":"publisher","first-page":"109411","DOI":"10.1016\/j.biopha.2019.109411","volume":"121","author":"W Wang","year":"2020","unstructured":"Wang, W., Jia, Y. J., Yang, Y. L., Xue, M., Zheng, Z. J., Wang, L., et al. (2020). LncRNA GAS5 exacerbates renal tubular epithelial fibrosis by acting as a competing endogenous RNA of miR-96-5p. Biomedicine & Pharmacotherapy, 121, 109411.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"3","key":"4385_CR33","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41419-020-2372-9","volume":"11","author":"T Xu","year":"2020","unstructured":"Xu, T., Lu, Z., Xiao, Z., Liu, F., Chen, Y., Wang, Z., et al. (2020). Myofibroblast induces hepatocyte-to-ductal metaplasia via laminin-avbeta6 integrin in liver fibrosis. Cell Death & Disease, 11(3), 199.","journal-title":"Cell Death & Disease"},{"key":"4385_CR34","doi-asserted-by":"publisher","first-page":"154140","DOI":"10.1016\/j.metabol.2020.154140","volume":"104","author":"Q Cai","year":"2020","unstructured":"Cai, Q., Chen, F., Xu, F., Wang, K., Zhang, K., Li, G., et al. (2020). Epigenetic silencing of microRNA-125b-5p promotes liver fibrosis in nonalcoholic fatty liver disease via integrin alpha8-mediated activation of RhoA signaling pathway. Metabolism, 104, 154140.","journal-title":"Metabolism"},{"issue":"4","key":"4385_CR35","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.apsb.2019.07.003","volume":"10","author":"W Li","year":"2020","unstructured":"Li, W., Zhou, C., Fu, Y., Chen, T., Liu, X., Zhang, Z., et al. (2020). Targeted delivery of hyaluronic acid nanomicelles to hepatic stellate cells in hepatic fibrosis rats. Acta Pharmaceutica Sinica B, 10(4), 693\u2013710.","journal-title":"Acta Pharmaceutica Sinica B"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-023-04385-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-023-04385-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-023-04385-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T13:11:18Z","timestamp":1699967478000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12010-023-04385-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,21]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["4385"],"URL":"https:\/\/doi.org\/10.1007\/s12010-023-04385-1","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,21]]},"assertion":[{"value":"17 February 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Protocols for animal experiments were approved by the Institutional Animal Care and Use Committee of Jiangsu University (protocol code: UJS-IACUC-2021030269).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The authors approve of the publication of the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"There authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}